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C.-M. Wahlgren* and E. WahlbergDepartment of Vascular Surgery, Karolinska University Hospital, Stockholm, 171 76 Stockholm, SwedenBackground. Thoracoabdominal aneurysm type IV (TAA IV) represents only a minority of aortic aneurysms, but as it is an
entirely abdominally located aneurysm, vascular surgeons are likely to see such aneurysms in their practice. The current
surgical management of TAA IV is reviewed.
Methods. A PubMed/Medline-literature search for TAA IV.
Results and Conclusions. A detailed preoperative evaluation to determine the rupture and operative risk is required. A
threshold size of 5.5–6 cm is recommended for elective repair of TAA IV, which then is adjusted for age and other risk factors.
Operative simplicity with the clamp and sew approach to obtain a short aortic cross-clamp time seems to have most support
in the literature. The necessity of adjunct treatment to prevent visceral and spinal cord ischemia seems to be needed rarely.
Uncomplicated repair has a minimal risk of neurological injury and a low risk of renal failure requiring dialysis in patients
without preoperative renal dysfunction or renal artery stenosis. The role of endovascular repair of these aneurysms remains
to be established.Keywords: Thoracoabdominal aneurysm type IV; Thoracoabdominal aneurysm; Renal ischemia; Visceral ischemia; Spinal
cord ischemia.Introduction
The repair of a thoracoabdominal aneurysm (TAA) is
perhaps one of the most challenging tasks in peripheral
vascular surgery. Hemodynamic derangement and
ischaemic injury to the kidneys, visceral organs and
spinal cord during operative management increase the
morbidity and mortality after the operation. TAAs are
uncommon when compared with isolated infrarenal
aneurysms. They compose no more than 2–5% of the
total spectrum and most vascular surgeons manage
only a few patients each year.
TAA type IV (TAA IV), according to Crawford’s
classification, begins at the level of the diaphragm and
terminates at the aortic bifurcation. TAA IV constitutes
about 20% of all patients treated for TAA in major
clinical series.1–3 It is located entirely within the
abdomen and therefore it is more likely to be handled
by vascular surgeons. The aim is to review the currenting author. Dr C.-M. Wahlgren, Department of
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assessment and conventional surgical strategies.Search Strategy Methods
All studies were identified by PubMed/Medline
searches between years 1966 and 2003. The following
two keywords were used: thoracoabdominal aneurysm
and thoracoabdominal aneurysm type IV. There were,
respectively, 843 and 50 items found in the search.
Articles for TAA IV management were selected and
references from these articles were also reviewed.
Because of the lack of prospective randomised trials
large observational studies were included. The selec-
tion process excluded experimental studies, small case
series, and most studies not including TAA IV. Articles
retrieved were restricted to those published in English.Etiology and Natural Course
Most TAAs (80–93%) are degenerative in nature withEur J Vasc Endovasc Surg 29, 116–123 (2005)
doi:10.1016/j.ejvs.2004.10.009, available online at http://www.sciencedirect.com onved.
Management of TAA IV 117an atherosclerotic etiology, but in 7–20% of cases TAA
are sequelae of chronic aortic dissection.1,4,5 Infection
and sequelae of previous aortitis account for a few
percent. Data on the natural history of TAA is limited
to a few studies6–8 and there are no studies reporting
specifically on TAA IV. Crawford et al. observed 94
patients with a non-operated TAA during a 25-year
period.7 Twenty-four percent of the patients were alive
at 2-years and half of the deaths were due to aneurysm
rupture. In contrast, the same group treated 604
patients surgically where 70% were alive at 2-years
and 59% at 5-years. The non-operated cohort included
only three patients with TAA IV. The aneurysm
ruptured in all three: two died. The number of TAA
IV was small because fewer of these patients were
rejected for surgical therapy. Bickerstaff et al. reported
an incidence of 5.9 new thoracic aortic aneurysms per
100,000 person-years over a 30-year period.8 The
incidence was equal in both sexes and decreased
slightly over time. In the group of 72 patients rupture
occurred in 53 patients (74%) of whom 50 died. The
5-year survival was 13%. However, no TAA IV was
included in that study.
There also are few studies of the natural history of
infrarenal abdominal aortic aneurysms (AAA). Schatz
et al. reported a 5-year survival of 36% in patients with
primarily asymptomatic aneurysms.9 The survival
was less than half that of age-matched controls and
one-third of all deaths were due to rupture. However,
most of the patients in that study had been considered
unfit for surgery. Since, in the 1960s surgical repair was
demonstrated to improve survival, initiation of a
prospective study delineating the natural course of
large AAA has been considered unethical.
The above studies demonstrated that the biologic
fate of all aneurysms is progressive enlargement and
rupture. Untreated aneurysms will cause death due to
rupture in a majority of patients. Operative repair is
the most effective means to alter the otherwise
dangerous course of TAA. Although not specifically
covered in the literature this is probably also appli-
cable to TAA IV.Size Threshold
A size threshold criterion for recommending operation
in patients with TAA IV is not clearly defined. As
previously mentioned, only a few patients with TAA
IV have been followed without intervention. Only for
AAA has the influence of size on rupture risk has been
firmly established. Szilagyi et al. demonstrated that
once the aneurysm had attained the size of above 6 cm
by physical examination, the risk of rupture increasedand the 5-year survival was lower.10 There appears to
be a transition point around a diameter of 5 cm below
which rupture risk is quite low and above which
rupture risk is quite high.11
Prospective studies have recommended elective
repair of AAA at a threshold diameter of 5 cm for
good risk patients and 6 cm for higher risk patients, or
for rapid expansion (O1 cm/year) or AAA that cause
symptoms.12,13 The UK small aneurysm trial demon-
strated that for infrarenal AAA with a diameter less
than 5.5 cm aortic replacement does not improve
survival for most patients.14 Cambria et al. followed
57 patients with TAA (12% type IV), managed non-
operatively, for 37 months.15 Rupture occurred in 14%
of these patients. The mean size of the ruptured TAAs
was 5.8 cm and no aneurysm less than 5 cm ruptured.
Another study of TAA stated that risk of rupture
increased fivefold when the 6 cm diameter threshold
was exceeded.16
Considering TAA IV is an entirely abdominal
aneurysm, the rupture risk may be comparable with
that of infrarenal aneurysms of equal size.17 It is
unknown if the arterial branches originating from the
TAA IV influence the rupture risk. The ratio of the
aneurysm diameter to the adjacent normal aorta
should also be included as a determinant for aneur-
ysm rupture. Thus, a 6 cm TAA IV in a small woman
with a 2.1 cm diameter of normal supraceliac aorta
would be considered at greater rupture risk than a
comparable 6 cm TAA IV in a large man with a 2.7 cm
diameter of normal supraceliac aorta. The greater
surgical risk for TAA also must be considered,
particularly since the supraceliac cross clamping may
cause ischaemic injury to visceral organs.18 Therefore,
based on the literature, we suggest a threshold size of
5.5–6 cm for elective repair of TAA IV. Of course this
limit needs to be adjusted if the patient have other co-
morbidities.Diagnosis and Preoperative Evaluation
Patients diagnosed as having a type IV TAA need a
detailed preoperative evaluation to determine the
rupture risk and operative strategy. The size of the
aneurysm is the most important predictor of rup-
ture.19,20 A CT scan or MRI is usually performed to
confirm the diagnosis and this investigation is gener-
ally sufficient for determining the extent of the
aneurysm as well as its size.21
MRI and spiral CT of good quality also enable
detailed mapping of the origins of the celiac axis,
superior mesenteric artery (SMA) and renal arteries,
which is important for planning the operation.22,23Eur J Vasc Endovasc Surg Vol 29, February 2005
C.-M. Wahlgren and E. Wahlberg118Information on the distance between the site for the
proximal anstomosis and the visceral arteries is
essential for determining if the origins of the right
renal artery, the celiac trunk and SMA should be
included in proximal anastomosis or if two separate
anastomoses are required. The CT and MRI examin-
ations can often also identify stenosis in visceral
vessels that may influence organ function postopera-
tively. Angiography is rarely needed for preoperative
evaluation of TAA type IV. Occasionally, when the CT
or MRI is not conclusive it may be useful for appraisal
of the visceral and renal vessels and its origins.
Almost two thirds of TAA patients have coronary
artery disease (CAD) and nearly half chronic obstruc-
tive pulmonary disease (COPD). Renal disease is
noted in around 40% of the patients.24,25 It is important
to evaluate the extent of concomitant disease when
selecting patients for operative treatment. The pre-
operative work up may include, besides routine
procedures, a cardiac stress test to identify patients
at risk of having unstable hemodynamics and heart
failure during aortic cross-clamping.26 Some authors
also recommend carotid duplex scanning to rule out
significant stenosis that may influence brain perfusion.
This recommendation is based on comments in the
literature stating that it may be wise to treat significant
CAD and carotid stenosis before aneurysm repair,27,28
but to our knowledge this has not been evaluated
specifically for TAA. As for AAA, it also probably is
wise to test with a history of COPD with spirometry
and have their pulmonary treatment optimised well
ahead of the time for surgery.29 A screening of renal
function with serum creatinine is mandatory. Bicknell
et al. suggested that patients with creatinine values
above 180 mmol/l should be treated conservatively.30
More common, however, is further examination of the
patients with elevated levels by determining creati-
nine clearance and then base the surgical risk
estimation on this latter value.Surgical Strategies
The intention is here to point out some important
strategies in repair of TAA IV. We refer to surgical
atlases and manuals for detailed information on
operative techniques. An incision through the 8th,
9th or 10th intercostal space with a retroperitoneal
thoracoabdominal approach is most often rec-
ommended.31–34 The thoracoabdominal incision
should be directed towards the umbilicus to prevent
necrosis of the lower skin flap.3 Postoperative pul-
monary function can be enhanced by dividing the
diaphragm circumferentially during surgery. IfEur J Vasc Endovasc Surg Vol 29, February 2005necessary, for the proximal anastomosis, the graft is
tunnelled through a separate incision in the crus.35 A
subcostal approach has been tried but was associated
with an unacceptably high complication rate, requir-
ing early re-operation.36
The general approach to the operative management
of TAA, described by Crawford, includes emphasis on
operative simplicity and expediency, minimal cross-
clamp times and avoidance of heparin.32 After
proximal cross-clamping, aortic reconstruction is
performed using the inlay technique.37 Accordingly,
the common method of TAA IV repair involves a
‘clamp and sew’ technique, sometimes complemented
with adjunct treatment to decrease renal and visceral
ischemia time. Another approach is the use of partial
cardiopulmonary bypass and distal aortic perfusion
techniques.38 Any benefit of distal aortic perfusion has
not been shown in a randomised controlled trial and in
the available retrospective reports its protective effect
on kidneys and viscera is unclear.39,40 There seem to be
more advantages of distal perfusion for other TAA
types and complex cases. For TAA IV distal perfusion
is time consuming and only saves the cross-clamping
time required to complete the proximal anastomosis.
Visceral perfusion catheters could also interfere with
surgical exposure.41
If possible the celiac, SMA, and right renal artery
orifices are included in the proximal anastomosis.34
This usually necessitates a long oblique anastomosis.
The left renal artery is then implanted separately onto
the body of the graft.42 It could also be reconstructed
with a side-arm graft to avoid kinking of the left renal
artery. The side-arm makes it easier to approximate the
appropriate length of the renal artery when viscera are
returned to their normal position. This strategy also
brings flexibility to deal with occlusive lesions and
multiple renal arteries.1 Ballard et al. presented a non-
randomised study on 20 elective cases of TAA IV
repaired with a trifurcated graft for sequential visceral
revascularization, followed by a second graft for inline
aneurysm reconstruction.43 The mean visceral ischae-
mic times were 12 min for both the celiac artery and
SMA, for the left renal artery 10 min and right renal
artery 33 min. There was no report of postoperative
renal failure but one patient with a previous AAA
repair had paraplegia.
The anastomosis distal to the aortic bifurcation or
the iliac arteries completes the reconstruction. When
the graft cross-clamp is released, blood-flow is
directed into the internal iliac arteries first, so that
debris not is flushed down into the external iliac
arteries.44
Endovascular repair for TAA IV is not yet generally
available and its role remains to be established.
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encouraging initial results,45 and there are reports of
TAA IV repair with a combined endovascular and
surgical procedure.46 Fenestrated stentgrafts also
appears to be a possible way to use endovascular
approaches to treat TAA IV, but need further
evaluation.47Outcome
Outcome of TAA IV repair varies considerable
depending whether the aneurysm is ruptured (Tables
1 and 2). The operative mortality for elective aneur-
ysms should be similar to that reported for infra-renal
AAA repair.1,49 Post-operative morbidities include
respiratory insufficiency, renal failure, neurological
deficit, stroke, myocardial infarction and wound
infection.49 The development of postoperative cardiac,
pulmonary, and renal complications is associated with
increased early mortality rates.1,5,35 The majority of
patients who die develop multiorgan failure after the
operation. In a cohort including all types of TAA, Cox
et al. showed that the causes of operative 30-day deaths
were multiorgan failure for 56% of the patients, with
myocardial infarction, and hemorrhage each 18%.4
Late events due to aortic disease or graft-related
complications occurred in at least 10% of 305 patients
undergoing TAA repair, of which 20% were TAA IV.48
There is also a risk of aneurysmal expansion of the
visceral patch, late after TAA repair. Of 107 patients
undergoing TAA repair, eight patients developed a
patch aneurysm on average 6.5-years after the original
operation.51 Limiting the visceral patch size at the
original operation by routinely reimplanting the left
renal artery separately followed by continuous sur-
veillance was recommended. Patients with connective
tissue disorders have a particularly high risk for
developing patch aneurysm.
There is evidence that high-risk surgery should
be performed in high-volume hospitals.52Table 1. Outcome of elective TAA IV repair
Author Study years
Cina` et al.31 1990–2001
Clouse et al.48 1987–2001
Bicknell et al.30 1993–2000
Le Maire et al.2 1986–1998
Martin et al.5 1989–1998
Schwartz et al.49 1977–1994
Gilling–Smith et al.50 1983–1993
Cox et al.4 1966–1991
Svensson et al.3 1960–1991
Total
* Including both acute and elective TAA IV repairs, with a majority oRegionalization and referral to high-volume providers
could benefit TAA surgery because of high procedure-
related morbidity and mortality. Cowan et al. showed
that hospitals with an annual volume of 5–31 TAA
repairs (median 12) and surgeons with an annual
operating volume of 3–18 cases (median 7) had a 42%
and a 58% reduction in mortality, respectively.53 An
annual surgeon volume of 1–2 cases does not appear
justified.Organ PreservationKidney
Renal failure remains a common complication after
complex aortic surgery, which greatly increases the
risk of mortality after TAA surgery.3,5,30 It is difficult to
compare the rate of postoperative renal failure
between different studies because of varying defi-
nitions and renal failure criteria used. The frequency of
postoperative dialysis, which is the most objective
definition available, is shown in Table 3: up to 15% of
the patients with TAA IV will need postoperative
dialysis. Given the strong association between need for
dialysis and mortality this complication is feared.
Minimising the need for dialysis is essential for
optimal TAA IV management.4,5,54
Nearly all patients undergoing TAA repair have
elevated serum creatinine levels after surgery. The
value usually peaks 2-days after the operation.
Kashyap et al. found that half of their study population
of 183 patients undergoing TAA surgery (16% had
TAA IV) showed no sign of deteriorating renal
function, creatinine less than 50% higher than the
baseline values.54 However, 40% of patients had
greater elevations in creatinine and required close
monitoring and 11% (21 patients) developed acute
renal failure. Five patients required hemodialysis of
whom three eventually died.
The most important variables that influencePatients, n 30-day mortality
42 2 (5%)
66 4 (6%)*
130 22 (17%)
207 8 (4%)
38 4 (11%)
58 3 (5%)
55 8 (15%)
24 3 (12%)
346 20 (6%)*
966 74 (7,7%)
f elective repairs.
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Table 2. Outcome of acute TAA IV repair
Author Study years Numbers, n 30-day
mortality
Martin et al.5 1989–1998 15 2 (13%)
Gilling-Smith et al.50 1983–1993 8 2 (25%)
Cox et al.4 1966–1991 18 10 (55%)
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renal insufficiency and aortic cross-clamp times.3,5,55
Schwartz et al. found in a retrospective review of 58
patients, all with TAA IV, that renal failure did not
occur if preoperative renal function was normal.49
Preoperative renal function therefore should influence
strongly selection to surgery.30 A renal ischaemic time
of up to 60 min seems safe, but the extent of suprarenal
cross-clamping time and the association with renal
failure is been inconsistent.5,18,54,56 For infra-renal
aortic disease procedures that required suprarenal
cross-clamping, the risk for a deteriorating renal
function was 10 times higher if clamping times were
longer than 50 min.57
The value of adjunct treatments to reduce renal
ischaemia is unclear. Renal hypothermia is beneficial
in renal surgery.58 Svensson et al. showed that cold
perfusion of the kidneys with Ringer’s lactate or
atriofemoral bypass did not significantly reduce the
need for dialysis following TAA surgery.39 The same
authors later observed that patients with visceral
vessel occlusive disease undergoing TAA repair
seemed to benefit from cold perfusion of the renal
arteries.59 Otherwise this group appeared to have an
especially high incidence of preoperative renal dys-
function. The risk of injury to the renal artery during
cannulation has been suggested to outweigh any
potential benefit of perfusion.50
In summary, careful preoperative evaluation can
reduce the risk of postoperative renal failure, but
intraoperative therapies such as cold renal perfusion,
do not appear to be beneficial for most patients
undergoing TAA IV repair. Possible exceptions are
those who have preoperative renal dysfunction orTable 3. Renal failure after TAA IV repair
Author and year N Renal failure
requiring
dialysis, n (%)
Renal
protection
Bicknell, 200330 130 20 (15%) NA
Cina`, 200231 42 6 (14%) Yes
LeMaire, 20012 207 11 (5%) Yes
Martin, 20005 76* 9 (12%) Yes
Schwartz, 199649 58 5 (9%) No
Gilling-Smith, 199550 63 9 (14%) No
NA, not available.
* Including TAA III (nZ38) and IV (nZ38).
Eur J Vasc Endovasc Surg Vol 29, February 2005renal artery occlusive disease and when clamp times
longer than approximately 45 min are expected.Viscera
Prolonged visceral ischemia when repairing TAA IV
has been associated with increased mortality.4,5,30,49,60
Bicknell et al. found a significantly higher mortality
rate in patients who had visceral ischemia for 40–
59 min (27%) than in those with ischaemia for
!40 min (9%).30 The highest mortality was in patients
who had visceral ischaemia for over 60 min (57%).
Vermeulen et al. also observed a higher complication
rate if mesenteric ischaemia was longer than 60 min.60
Different methods of reducing visceral ischemia have
been proposed. Examples are selective visceral artery
perfusion using extracorporeal circulation and shunting
of the visceral arteries via a side-arm of the graft.61–63
Revascularization by endarterectomy or bypass has a
role in selected cases to improve the outcome of
mesenteric occlusive disease.33
It is obvious that visceral ischemia should be kept to
a minimum, but the rationale is relatively weak for
using adjunct therapy to reduce visceral ischemia in
uncomplicated repair of TAA IV with a single
proximal anastomosis including the visceral arteries.
If a separate proximal end-to-end anastomosis is
anticipated, mesenteric shunting is probably beneficial
and recommended.Spinal cord
Theoretically patients with TAA IV have a low risk of
spinal cord injury because of avoidance of mid or
upper thoracic aortic clamping. Table 4 summarises
the reported neurological outcomes in TAA IV repair.
Univariate analysis confirmed that TAA IV was
associated with a lower risk of paraplegia compared
to more extensive TAAs.64 The risk of spinal cord
injury was higher in patients with more extensive
TAA, long aortic cross-clamp duration, and for
emergency operations.1,5,64 This might be true also
for TAA IV. Paraplegia after TAA IV repair is more
prominent after emergency repair of ruptured aneur-
ysms.4,5,31 (Table 4). It also is possible that the risk for
paraplegia/paraparesis in TAA IV repair increases if
aortic clamp time exceeds 45 min.3
Although many strategies have been proposed to
limit spinal cord ischemia when repairing TAA, none
is proven to be effective. Examples of adjunct treat-
ments are: cerebrospinal fluid drainage, reimplanta-
tion of intercostal arteries, epidural cooling, aortic
shunting via bypass and administration of different
Table 4. Neurologic outcome after TAA IV repair
Author and year Neurologic deficit Adjuncts
Elective surgery Acute surgery
LeMaire, 200364 3/225 (1%) No
Bicknell, 200330 5/130 (4%) No
Safi, 200338 1/145 (1%)* CSFDCdistal aortic perfusion
Cina`, 200231 0/42 (0%) 1/7 (14%) No
Cambria, 200265 1/65 (2%)* Intercostal artery reattachment (33%)
Martin, 20005 0/38 (0%) 1/15 (7%) CSFD (discretion of surgeon)
Schwartz, 199649 2/58 (3%) CSFD (36% of patients)
Gilling-Smith, 199550 0/55 (0%) 0/8 (0%) No
Svensson, 19933 15/346 (4%)* NA
Cox, 19924 1/24 (4%) 3/15 (20%) CSFD
Hollier, 199266 0/53 (0%) CSFD (11% of pateints)
CSFD, cerebrospinal fluid drainage; NA, not available.
* Including both acute and elective surgery.
Management of TAA IV 121neuroprotective pharmacologic agents.41 It is difficult
to evaluate the benefit of these different approaches for
TAA IV repair because no thorough evaluation for has
been done and often several adjunct treatments are
combined. A recent Cochrane review found limited
data to support cerebrospinal fluid (CSF) drainage in
TAA I or II surgery to prevent of neurological injury.67
In TAA IV repair, the use of CSF drainage has not
reduced neurological deficit frequency.5,49 Proximal
hypertension during cross-clamping, avoidance of
hyperglycemia and minimising reperfusion injury by
the use of mannitol are simple measures that could be
easily accomplished.66
Uncomplicated repair of TAA IV has a minimal risk
for neurological injury. There is no evidence for using
adjunct treatments to prevent spinal cord ischemia,
during TAA IV repair, or indicate the superiority of a
particular strategy.Summary
TAA IV represents a minority of all aortic aneurysms,
but as it is an entirely abdominally located aneurysm,
vascular surgeons will come across these aneurysms in
their practice. A detailed preoperative evaluation to
determine the rupture risk and operative strategy is
mandatory. It is especially important to appraise if it is
possible to perform a single proximal anastomosis,
which includes the visceral artery orifices. A threshold
size of 5.5–6 cm for elective repair of TAA IV is
recommended, to be adjusted for age and other risk
factors. The simple approach of clamp and sew
operation to obtain a short aortic cross-clamp time
seems to have most support in the literature. In spite of
suggestions that different techniques reduce the like-
lihood of visceral and spinal cord ischemia during
TAA IV repair, adjunct treatments seem to rarely be
needed. Uncomplicated repair has a minimal risk ofneurological injury and a low risk of renal failure
requiring dialysis in patients without preoperative
renal dysfunction or renal artery stenosis. Further
clinical and experimental studies are indicated to
optimise treatment of TAA IV and reduce the risk of
postoperative complications. The role of endovascular
repair of these aneurysms remains to be established.References
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